Ektacytometry Analysis of Post-splenectomy Red Blood Cell Properties Identifies Cell Membrane Stability Test as a Novel Biomarker of Membrane Health in Hereditary Spherocytosis

por Berrevoets, M. C., Bos, J., Huisjes, R., Merkx, T. H., van Oirschot, B. A., van Solinge, W. W., Verweij, J. W., Lindeboom, M. Y. A., van Beers, E. J., Bartels, M., van Wijk, R., Rab, M. A. E.
Publicado 2021

P1065: CONGENITAL ERYTHROCYTOSIS DUE TO HETEROZYGOUS VARIANTS IN THE BISPHOSPHOGLYCERATE MUTASE GENE

por van Dijk, M. J., van Oirschot, B. A., Stam-Slob, M. C., van der Zwaag, B., van Beers, E. J., Jans, J. J., van der Linden, P., Torregrosa Diaz, J. M., Gardie, B., Girodon, F., Schots, R., Thielen, N., van Wijk, R.
Publicado 2022

P1501: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE...

por van Dijk, M. J., Rab, M. A., van Oirschot, B. A., Bos, J., Derichs, C., Rijneveld, A. W., Cnossen, M. H., Nur, E., Biemond, B. J., Bartels, M., Jans, J. J., van Solinge, W. W., Schutgens, R. E., van Wijk, R., van Beers, E. J.
Publicado 2022

5589320 FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE...

por van Dijk, M.J., Rab, M.A.E., van Oirschot, B.A., Bos, J.F., Derichs, C., Rijneveld, A.W., Cnossen, M.H., Nur, E., Biemond, B.J., Bartels, M., Jans, J.J.M., van Solinge, W.W., Schutgens, R.E.G., van Wijk, R., van Beers, E.J.
Publicado 2023